Analyst Price Targets — CERT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 5, 2026 9:07 am | — | Barclays | $7.50 | $7.80 | TheFly | Certara price target raised to $7.50 from $6.50 at Barclays |
| May 12, 2026 1:18 pm | — | Craig-Hallum | $8.00 | $5.03 | TheFly | Certara price target lowered to $8 from $10 at Craig-Hallum |
| February 26, 2026 6:08 pm | Michael Cherny | Leerink Partners | $10.00 | $6.61 | StreetInsider | Certara Inc. (CERT) PT Lowered to $10 at Leerink Partners |
| January 6, 2026 12:33 pm | Certara to Outperform | Leerink Partners | $13.00 | $9.04 | TheFly | Certara upgraded to Outperform from Market Perform at Leerink |
| November 21, 2025 9:45 am | — | Redburn Partners | $10.00 | $8.03 | TheFly | Certara initiated with a Buy at Rothschild & Co Redburn |
| September 29, 2025 11:13 am | — | Craig-Hallum | $16.00 | $11.80 | TheFly | Certara initiated with a Buy at Craig-Hallum |
| November 5, 2024 11:50 am | Joe Vruwink | Robert W. Baird | $13.00 | $10.31 | StreetInsider | Certara Inc. (CERT) PT Lowered to $13 at Baird |
| September 27, 2024 5:22 am | Dan Leonard | UBS | $16.00 | $10.70 | TheFly | Certara upgraded to Buy from Neutral at UBS |
| June 28, 2024 5:28 am | Luke Sergott | Barclays | $16.00 | $13.65 | TheFly | Certara price target lowered to $16 from $18 at Barclays |
| April 10, 2024 1:31 am | Scott Schoenhaus | KeyBanc | $23.00 | $18.51 | StreetInsider | KeyBanc Upgrades Certara Inc. (CERT) to Overweight |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for CERT

Definitive Healthcare (NASDAQ: DH - Get Free Report) and Certara (NASDAQ: CERT - Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, earnings, profitability, analyst recommendations, risk, institutional ownership and valuation. Insider and Institutional Ownership 98.7% of Definitive Healthcare

BlackRock Inc. purchased a new position in shares of Certara, Inc. (NASDAQ: CERT) during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 18,818,180 shares of the company's stock, valued at approximately $123,259,000. BlackRock Inc. owned about 12.34% of Certara at

Cerrado Gold Inc. (CERT:CA) Q2 2026 Earnings Call Transcript

Certara, Inc. (CERT) Q2 2026 Earnings Call Transcript

Certara NASDAQ: CERT reported second-quarter 2026 revenue of $93.3 million, up 1% year over year, as software growth offset a decline in services revenue. Management reaffirmed its full-year revenue outlook while outlining further changes to its commercial organization, cost structure and artificial intelligence strategy.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CERT.
U.S. House Trading
No House trades found for CERT.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
